메뉴 건너뛰기




Volumn 113, Issue 12, 2006, Pages 1909-1913

Effect of cabergoline added to levodopa treatment on sleep-wake cycle in idiopathic Parkinson's disease: An open label 24-hour polysomnographic study

Author keywords

Cabergoline; Epworth Sleepiness Scale; Excessive daytime somnolence; Parkinson's disease; Parkinson's disease Sleep Scale; Polysomnography; Sleep

Indexed keywords

CABERGOLINE; LEVODOPA;

EID: 33750985391     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-006-0490-x     Document Type: Article
Times cited : (26)

References (39)
  • 2
    • 0027480823 scopus 로고
    • Sleep in Parkinson's disease
    • JJ Askenasy 1993 Sleep in Parkinson's disease Acta Neurologica Scan 87 167 170
    • (1993) Acta Neurologica Scan , vol.87 , pp. 167-170
    • Askenasy, J.J.1
  • 3
    • 0035655161 scopus 로고    scopus 로고
    • Efficacy of cabergoline in long term use: Results of three observational studies in 1500 patients with Parkinson's disease
    • Suppl 1
    • HKJ Baas P Schueler 2001 Efficacy of cabergoline in long term use: results of three observational studies in 1500 patients with Parkinson's disease Eur Neurol 46 Suppl 1 18 23
    • (2001) Eur Neurol , vol.46 , pp. 18-23
    • Baas, H.K.J.1    Schueler, P.2
  • 4
    • 0026707833 scopus 로고
    • Multiple sleep latency tests during the constant routine
    • MA Carskadon WC Dement 1992 Multiple sleep latency tests during the constant routine Sleep 15 396 399
    • (1992) Sleep , vol.15 , pp. 396-399
    • Carskadon, M.A.1    Dement, W.C.2
  • 5
    • 0035657538 scopus 로고    scopus 로고
    • Achieving 24-hour control of Parkinson's disease symptoms: Use of objective measures to improve nocturnal disability
    • Suppl 1
    • KR Chaudhuri S Pal K Bridgman C Trenkwalder 2001 Achieving 24-hour control of Parkinson's disease symptoms: use of objective measures to improve nocturnal disability Eur Neurol 46 Suppl 1 3 10
    • (2001) Eur Neurol , vol.46 , pp. 3-10
    • Chaudhuri, K.R.1    Pal, S.2    Bridgman, K.3    Trenkwalder, C.4
  • 7
    • 0036318799 scopus 로고    scopus 로고
    • 'Sleep attacks' or 'unintended sleep episodes' occur whit dopamine agonists: Is this a class effect?
    • KR Chaudhuri S Pal C Brefel-Courbon 2002b 'Sleep attacks' or 'unintended sleep episodes' occur whit dopamine agonists: is this a class effect? Drug Saf 25 473 483
    • (2002) Drug Saf , vol.25 , pp. 473-483
    • Chaudhuri, K.R.1    Pal, S.2    Brefel-Courbon, C.3
  • 8
    • 7044251841 scopus 로고    scopus 로고
    • Clinical assessment of nocturnal disability in Parkinson's disease: The Parkinson's disease Sleep Scale
    • Suppl 3
    • KR Chaudhuri P Martinez-Martin 2004 Clinical assessment of nocturnal disability in Parkinson's disease: the Parkinson's disease Sleep Scale Neurology 63 Suppl 3 S17 S20
    • (2004) Neurology , vol.63
    • Chaudhuri, K.R.1    Martinez-Martin, P.2
  • 9
    • 0019156739 scopus 로고
    • Periodic movements in sleep (nocturnal myoclonus): Relation to sleep disorder
    • RM Coleman CP Pollak ED Weitzman 1980 Periodic movements in sleep (nocturnal myoclonus): relation to sleep disorder Ann Neurol 8 416 421
    • (1980) Ann Neurol , vol.8 , pp. 416-421
    • Coleman, R.M.1    Pollak, C.P.2    Weitzman, E.D.3
  • 10
    • 0142217553 scopus 로고    scopus 로고
    • Bedtime cabergoline in Parkinson's disease patients with excessive daytime sleepiness induced by dopamine agonists
    • P Del Dotto G Gambaccini D Caneparo C Berti S Bernardini U Bonuccelli 2003 Bedtime cabergoline in Parkinson's disease patients with excessive daytime sleepiness induced by dopamine agonists Neurol Sci 24 170 171
    • (2003) Neurol Sci , vol.24 , pp. 170-171
    • Del Dotto, P.1    Gambaccini, G.2    Caneparo, D.3    Berti, C.4    Bernardini, S.5    Bonuccelli, U.6
  • 12
    • 0000224448 scopus 로고    scopus 로고
    • Unified Parkinson's disease rating scale
    • Members of the UPDRS development committee Fahn S, Marsden CD, Calne DB, Goldstein M (eds) MacMillan Healthcare Information: Florham Park, NY, 293-304
    • Fahn S, Elton RL, Members of the UPDRS development committee (1997) Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M (eds) Recent development in Parkinson's disease, Vol. 2 MacMillan Healthcare Information: Florham Park, NY, pp 153-163, 293-304
    • (1997) Recent Development in Parkinson's Disease , vol.2 , pp. 153-163
    • Fahn, S.1    Elton, R.L.2
  • 13
    • 0031975426 scopus 로고    scopus 로고
    • Pharmacodynamic and pharmacokinetic features of cabergoline. Rationale for use in Parkinson's disease
    • Suppl 1
    • RG Fariello 1998 Pharmacodynamic and pharmacokinetic features of cabergoline. Rationale for use in Parkinson's disease Drugs 55 Suppl 1 10 16
    • (1998) Drugs , vol.55 , pp. 10-16
    • Fariello, R.G.1
  • 15
    • 0032975093 scopus 로고    scopus 로고
    • Falling asleep at the wheel: Motor vehicle mishaps in person taking pramipexole and ropirinole
    • S Frucht JD Rogers PE Greene MF Gordon S Fahn 1999 Falling asleep at the wheel: motor vehicle mishaps in person taking pramipexole and ropirinole Neurology 52 1908 1910
    • (1999) Neurology , vol.52 , pp. 1908-1910
    • Frucht, S.1    Rogers, J.D.2    Greene, P.E.3    Gordon, M.F.4    Fahn, S.5
  • 18
    • 0032918088 scopus 로고    scopus 로고
    • Switching dopamine agonists in advanced Parkinson's disease: Is rapid titration preferable to slow?
    • CG Goetz L Blasucci GT Stebbins 1999 Switching dopamine agonists in advanced Parkinson's disease: is rapid titration preferable to slow? Neurology 52 1227 1229
    • (1999) Neurology , vol.52 , pp. 1227-1229
    • Goetz, C.G.1    Blasucci, L.2    Stebbins, G.T.3
  • 19
    • 8844285228 scopus 로고    scopus 로고
    • Switching from ergot to nonergot dopamine agonists in Parkinson's disease: A clinical series and five-drug dose conversion table
    • K Grosset F Needleman G Macphee D Grosset 2004 Switching from ergot to nonergot dopamine agonists in Parkinson's disease: a clinical series and five-drug dose conversion table Mov Disord Nov 19 370 374
    • (2004) Mov Disord Nov , vol.19 , pp. 370-374
    • Grosset, K.1    Needleman, F.2    MacPhee, G.3    Grosset, D.4
  • 20
    • 0344258740 scopus 로고    scopus 로고
    • The effect of cabergoline on sleep, periodic leg movements in sleep, and early morning motor function in patients with Parkinson's diesease
    • B Hogl A Rothdach TC Wetter C Trenkwalder 2003 The effect of cabergoline on sleep, periodic leg movements in sleep, and early morning motor function in patients with Parkinson's diesease Neuropsychopharmacology 28 1866 1870
    • (2003) Neuropsychopharmacology , vol.28 , pp. 1866-1870
    • Hogl, B.1    Rothdach, A.2    Wetter, T.C.3    Trenkwalder, C.4
  • 22
    • 0026333617 scopus 로고
    • A new method for measuring daytime sleepiness: The Epworth sleepiness scale
    • MW Johns 1991 A new method for measuring daytime sleepiness: the Epworth sleepiness scale Sleep 14 540 545
    • (1991) Sleep , vol.14 , pp. 540-545
    • Johns, M.W.1
  • 23
    • 0001037428 scopus 로고    scopus 로고
    • Excessive daytime somnolence and sudden onset sleep in Parkinson's disease: A survey from 18 Canadian movement disorders clinics
    • Suppl 3
    • AE Lang DE Hobson W Martin J Rivest 2001 Excessive daytime somnolence and sudden onset sleep in Parkinson's disease: a survey from 18 Canadian movement disorders clinics Neurology 56 Suppl 3 A212 A213
    • (2001) Neurology , vol.56
    • Lang, A.E.1    Hobson, D.E.2    Martin, W.3    Rivest, J.4
  • 24
    • 0027741296 scopus 로고
    • Cabergoline in Parkinson's disease: Long term follow-up
    • G Lera J Vaamonde M Rodriguez JA Obeso 1993 Cabergoline in Parkinson's disease: long term follow-up Neurology 43 2587 2590
    • (1993) Neurology , vol.43 , pp. 2587-2590
    • Lera, G.1    Vaamonde, J.2    Rodriguez, M.3    Obeso, J.A.4
  • 25
    • 0020353081 scopus 로고
    • Sleep disruption in the course of chronic levodopa therapy: An early feature of the levodopa psychosis
    • PA Nausieda WJ Weiner LR Kaplan S Weber HL Klawans 1982 Sleep disruption in the course of chronic levodopa therapy: an early feature of the levodopa psychosis Clin Neuropharmacol 5 183 194
    • (1982) Clin Neuropharmacol , vol.5 , pp. 183-194
    • Nausieda, P.A.1    Weiner, W.J.2    Kaplan, L.R.3    Weber, S.4    Klawans, H.L.5
  • 26
    • 0034028678 scopus 로고    scopus 로고
    • Waking up to sleep episodes in Parkinson's disease
    • CW Olanow AH Schapira T Roth 2000 Waking up to sleep episodes in Parkinson's disease Mov Disord 15 212 215
    • (2000) Mov Disord , vol.15 , pp. 212-215
    • Olanow, C.W.1    Schapira, A.H.2    Roth, T.3
  • 28
    • 0034924694 scopus 로고    scopus 로고
    • A study of excessive daytime sleepiness and its clinical significance in three groups of Parkinson's disease patients taking pramipexole cabergoline and levodopa mono and combination therapy
    • S Pal KF Bhattacharya C Agapito KR Chaudhuri 2001 A study of excessive daytime sleepiness and its clinical significance in three groups of Parkinson's disease patients taking pramipexole cabergoline and levodopa mono and combination therapy J Neural Transm 108 71 77
    • (2001) J Neural Transm , vol.108 , pp. 71-77
    • Pal, S.1    Bhattacharya, K.F.2    Agapito, C.3    Chaudhuri, K.R.4
  • 30
    • 0033860135 scopus 로고    scopus 로고
    • Parkinson's disease and sleep
    • W Poewe B Hogl 2000 Parkinson's disease and sleep Curr Opin Neurol 13 423 426
    • (2000) Curr Opin Neurol , vol.13 , pp. 423-426
    • Poewe, W.1    Hogl, B.2
  • 32
    • 10644285526 scopus 로고    scopus 로고
    • Sleep episodes and daytime somnolence as result of individual susceptibility to different dopaminergic drugs in a PD patient: A polysomnographic study
    • A Romigi L Brusa MG Marciani M Pierantozzi F Placidi F Izzi F Sperli F Testa P Stanzione 2005 Sleep episodes and daytime somnolence as result of individual susceptibility to different dopaminergic drugs in a PD patient: a polysomnographic study J Neurol Sci 228 7 10
    • (2005) J Neurol Sci , vol.228 , pp. 7-10
    • Romigi, A.1    Brusa, L.2    Marciani, M.G.3    Pierantozzi, M.4    Placidi, F.5    Izzi, F.6    Sperli, F.7    Testa, F.8    Stanzione, P.9
  • 33
    • 85047172180 scopus 로고    scopus 로고
    • L-dopa-induced excessive daytime somnolence in PD. a placebo-controlled case with MSLT assessment
    • A Romigi MG Marciani F Placidi 2004 L-dopa-induced excessive daytime somnolence in PD. A placebo-controlled case with MSLT assessment Neurology 62 1454
    • (2004) Neurology , vol.62 , pp. 1454
    • Romigi, A.1    Marciani, M.G.2    Placidi, F.3
  • 34
    • 0037065828 scopus 로고    scopus 로고
    • Emerging views of dopamine in modulation sleep/wake state from unlike source: PD
    • DB Rye J Jankovic 2002 Emerging views of dopamine in modulation sleep/wake state from unlike source: PD Neurology 58 341 346
    • (2002) Neurology , vol.58 , pp. 341-346
    • Rye, D.B.1    Jankovic, J.2
  • 36
    • 0031770530 scopus 로고    scopus 로고
    • A community-based study of sleep disorders in patients with Parkinson'disease
    • E Tandberg JP Larsen K Karlsen 1998 A community-based study of sleep disorders in patients with Parkinson'disease Mov Disord 13 895 899
    • (1998) Mov Disord , vol.13 , pp. 895-899
    • Tandberg, E.1    Larsen, J.P.2    Karlsen, K.3
  • 39
    • 0034194661 scopus 로고    scopus 로고
    • Sleep and periodic leg movement pattern in drug-free patient with Parkinson's disease and multiple system atrophy
    • TC Wetter V Collado-Seidel T Pollmacher SA Yassouridi C Trenkwalder 2000 Sleep and periodic leg movement pattern in drug-free patient with Parkinson's disease and multiple system atrophy Sleep 23 361 367
    • (2000) Sleep , vol.23 , pp. 361-367
    • Wetter, T.C.1    Collado-Seidel, V.2    Pollmacher, T.3    Yassouridi, S.A.4    Trenkwalder, C.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.